Use of glucocorticoids in covid 19 patients: systematic review
Open Access
- 27 January 2021
- journal article
- review article
- Published by MedCrave Group Kft. in Pharmacy & Pharmacology International Journal
- Vol. 9 (1), 7-9
- https://doi.org/10.15406/ppij.2020.09.00318
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Dexamethasone or hydrocortisone in COVID-19?Cleveland Clinic Journal of Medicine, 2020
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19JAMA, 2020
- Hydroxychloroquine and dexamethasone in COVID-19: who won and who lost?Clinical and Molecular Allergy, 2020
- Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetesDiabetic Medicine, 2020
- COVID-19-PneumonieDer Internist, 2020
- Advances in the possible treatment of COVID-19: A review.European Journal of Pharmacology, 2020
- The use of dexamethasone in the treatment of COVID-19Annals of Medicine & Surgery, 2020
- Dexamethasone in the management of covid -19BMJ, 2020
- Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspectiveDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- A critical evaluation of glucocorticoids in the management of severe COVID-19Cytokine & Growth Factor Reviews, 2020